Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
about
Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemiaA new drug design targeting the adenosinergic system for Huntington's diseaseGDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson diseaseGDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's diseaseInactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease.Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia.Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learningFunctional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotectionTuning and fine-tuning of synapses with adenosine.Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.Constitutive activity of the A2A adenosine receptor and compartmentalised cyclic AMP signalling fine-tune noradrenaline release.The timing and location of glial cell line-derived neurotrophic factor expression determine enteric nervous system structure and function.
P2860
Q26851322-AA4A3079-D389-4846-8621-180D29C0E5C8Q27335053-89D29EB8-6CCA-44AE-9287-2AC465627669Q28083626-50253086-9CA7-4407-8F7A-2C173CDD0F70Q28088320-80A53D94-2E34-491D-8B14-19823C7D88DEQ33645872-1D7B181B-5630-4D06-AF1C-F5B4749B23EAQ36597141-E946F710-A2C2-48F3-922D-B8AECF9B948AQ36674667-5A3F53F3-B55D-4FD9-AB74-23EA2752C4DFQ37046788-EA95D621-1739-4ABE-ACFE-891EE8CE61F1Q37176918-48043F4B-E18F-4C63-B143-ECC92AD5E9D5Q37512421-87C3FB96-0410-4446-BF1F-E7A483CB4DB3Q37700201-FDAFB62F-E535-46EE-8479-0F9749AC2138Q38194531-66D8F9BD-3773-4316-9E25-3E1B6187EC11Q38711758-AC487B10-C63F-470F-B4E2-BE9C5291C59CQ38844409-37F93636-005D-4098-AFA6-79FBC335B8A8Q39369205-10B996F4-0F70-4BF4-B0CE-58E44C7D8697Q39562120-1A2E8C8A-79E7-4C6F-ACD9-D28044536F6D
P2860
Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Glial cell line-derived neurot ...... A2A receptor-dependent manner.
@en
type
label
Glial cell line-derived neurot ...... A2A receptor-dependent manner.
@en
prefLabel
Glial cell line-derived neurot ...... A2A receptor-dependent manner.
@en
P2093
P50
P1433
P1476
Glial cell line-derived neurot ...... A2A receptor-dependent manner
@en
P2093
Ana M Sebastião
Joaquim A Ribeiro
Sandra H Vaz
P304
P356
10.1016/J.BRAINRES.2006.07.025
P577
2006-08-28T00:00:00Z